Drug abuse treatment as AIDS prevention. - Wikidata - awgldk - TriplyDB

Drug abuse treatment as AIDS prevention.

Drug abuse treatment as AIDS prevention.

http://www.wikidata.org/entity/Q34196421

about

Behavioral and biomedical combination strategies for HIV prevention The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals Men in methadone maintenance versus psychosocial outpatient treatment: differences in sexual risk behaviors and intervention effectiveness from a multisite HIV prevention intervention trial.Persistence of low drug treatment coverage for injection drug users in large US metropolitan areas Reducing HIV-risk behavior among adults receiving outpatient psychiatric treatment: results from a randomized controlled trial Injection drug use among stimulant users in a national sample What we have learned from research about the prevention of HIV transmission among drug abusers Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations.Black-white disparities in HIV/AIDS: the role of drug policy and the corrections system HIV risks and seroprevalence among Mexican American injection drug users in California Needle-exchange attendance and health care utilization promote entry into detoxification.Toward a comprehensive approach to HIV prevention for people who use drugs.The interplay between interpersonal dynamics, treatment barriers, and larger social forces: an exploratory study of drug-using couples in Hartford, CT Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention.Prevention and treatment of hepatitis C in injection drug users.Substance abuse treatment as HIV prevention: more questions than answers Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility.HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study.Drug treatment as HIV prevention: a research update Drug treatment as HIV prevention: expanding treatment options.[Injecting without getting infected: injectors' strategies to prevent HIV and HCV.]The urgency of providing comprehensive and integrated treatment for substance abusers with HIV Screening and brief intervention for substance misuse: Does it reduce aggression and HIV-related risk behaviours?HIV prevention among injection drug users: the need for integrated models.Optimizing a community-friendly HIV risk reduction intervention for injection drug users in treatment: a structural equation modeling approach.Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity.Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs.Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: results from the EDGE study NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.The influence of a peer-based HIV prevention intervention on conversation about HIV prevention among people who inject drugs in Baltimore, Maryland Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area Challenges in motivating treatment enrollment in community syringe exchange participants.Attitudes and practices regarding the use of methadone in US state and federal prisons The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units Beliefs about methadone in an inner-city methadone clinic.Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC).Analyzing HIV/AIDS and Alcohol and Other Drug Use as a Social Problem.

P2860

Q27001172-16BCFE4B-537F-48C7-9BFD-A2F5B7C10592 Q28205170-458CDA5D-0312-4FA5-8E3A-BAEB784AA41E Q30495573-8258A3EC-48F3-4282-8EBD-832D9093DF6F Q30496986-C831151D-2DAB-4CB0-822F-AEC254BC4E45 Q34092963-4931DDDC-3CE6-4A26-8A00-7D2E51391902 Q34195746-43001D3F-1C60-4F13-B444-14F73A73EDD0 Q34196496-7FB6B996-78D2-4F39-AAEA-CABB3F14B045 Q34335886-4141B963-EDFB-494A-9042-1F86E811EF58 Q34422290-F70D62DF-B779-47B0-9AB5-DE4E225127A8 Q34500961-12354DA8-2FC9-4339-BFA9-1E0CD556898A Q34506338-05F0807E-41F2-4052-9787-3DC9BEDFBC3B Q34781762-C087A290-61FD-4B6C-821E-7091A472C561 Q34880522-84EE336C-F5D0-42D1-9650-B69D185A9908 Q34890135-D375DA29-95C0-48D8-9D79-A999D63CC005 Q34984130-9CBC0794-D25F-47A8-A085-FD675151CC98 Q34991140-FBE7BF01-AB15-4B03-8330-CFF44167BF17 Q35008495-2EF481E4-4916-46BB-967A-7A299731B64D Q35120376-27F0E085-13B9-43AC-B11D-9CADDE9CDEB6 Q35127554-02921354-B2C7-409C-850F-B93864C3BC44 Q35143605-EC34C752-62EC-494D-A651-400553E22A15 Q35163392-A16B5CA0-CEDD-4065-AA82-4CE7D57D459B Q35163396-10EA0F81-6357-4580-BB93-018A92CBC9AC Q35207698-114DD581-3711-411C-BE1C-1E506DAE399A Q35308404-7750098A-4200-4BF4-979F-7BCA9F1F4DDC Q35438800-24C792D6-C7C7-4D74-B31C-B39147806AD5 Q35624688-1F6129EE-85F0-4420-8079-3BFDC8E8EB27 Q35680763-95AB1F17-AF95-4BC7-BFBA-8C928EBB0D48 Q35737654-ADACFC16-2747-44F4-850C-E1676C572BEF Q35763921-F46A1DBF-695D-4B58-BAFC-91243D4803B7 Q35836781-E121447D-96D6-4349-82F8-A70368541DE5 Q35865410-09B56B2E-5C8D-4EF9-BD99-216D2A953532 Q35990579-FC45F453-1011-4263-B18C-61BEF4EC94BB Q36052814-ADF4D3A1-2CAA-45D3-B913-A9CF0D0BDFBD Q36272739-F02554C7-350B-41AB-BBFA-7A8FD3D94DD4 Q36272795-17DEF708-8EBA-4836-887F-92AC5B806315 Q36272833-EB78D4EA-C6E7-484C-9FEA-2E45123D97E9 Q36273036-6FDC2646-2405-490D-A547-48504373B95F Q36274813-92F7A514-5CA6-4265-B7F4-B9806181ECF0 Q36392409-6CAD1B4A-5366-4CBF-AB2F-67C0618E677F Q36477765-A11DD488-A6A8-49B7-ADD3-17B9B3339A9A

P2860

Drug abuse treatment as AIDS prevention.

http://www.wikidata.org/entity/Q34196421

description

1998 nî lūn-bûn

@nan

1998 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Drug abuse treatment as AIDS prevention.

@ast

Drug abuse treatment as AIDS prevention.

@en

Drug abuse treatment as AIDS prevention.

@nl

type

label

Drug abuse treatment as AIDS prevention.

@ast

Drug abuse treatment as AIDS prevention.

@en

Drug abuse treatment as AIDS prevention.

@nl

prefLabel

Drug abuse treatment as AIDS prevention.

@ast

Drug abuse treatment as AIDS prevention.

@en

Drug abuse treatment as AIDS prevention.

@nl

P1433

Q34196421-C99EBAEB-833D-41BE-8C77-6BAEC48EB5B2

P1476

Q34196421-30164BC4-4910-4997-A3EC-DBAD686E1773

P2093

Q34196421-0E28869C-B804-4426-9B25-AF33379BC489

Q34196421-3BF5B41E-8CE3-4115-87FA-9F7E4CEA034F

Q34196421-9C7F301C-AD94-4BA3-9743-EB84F3B675EA

P2860

Q34196421-01AE2FA1-53D4-42E8-A527-2A6B65DE49D9

Q34196421-09852247-D499-4AFF-ADAD-89F50F67F80D

Q34196421-18B5609D-2DD9-4430-AA70-8D8B1F01D49A

Q34196421-1F7335AB-7D9D-4B25-A337-52658E6DA1E1

Q34196421-2EB01B8D-5B09-4E7E-BCA4-274DB423D6D9

Q34196421-3C0956EC-461E-477D-824D-1BE5E7683639

Q34196421-3C9D1803-C464-4C33-89EA-2D2D75BFFF30

Q34196421-3EB88D6C-A32F-4B0C-8604-4E33E82CE941

Q34196421-5113807E-7917-4C4F-AE79-887105F5ED63

Q34196421-5585B230-9797-48F1-B6F4-A8778EC63F02

P304

Q34196421-6A73F8D6-D94D-4B07-A73E-8F4671AA1EDE

P31

Q34196421-7996BE98-6E3C-40C6-8128-D35F4832AD1A

P478

Q34196421-4CD25F55-24F4-4FBA-8B67-10D4E47FE19B

P577

Q34196421-34DEB0F0-FF4C-4FE7-9287-37C775B9CB1A

P698

Q34196421-49D6137D-9532-48C2-8982-DE018B23E8C4

P921

Q34196421-2BA742F2-8B85-4D3C-B807-B7B2CD9B3BF1

P932

Q34196421-CB0B7098-9958-4C90-ABC2-FE36E9E28E19

P1433

Public Health Reports

P1476

Drug abuse treatment as AIDS prevention

@en

P2093

Metzger DS

http://www.w3.org/2001/XMLSchema#string

Navaline H

http://www.w3.org/2001/XMLSchema#string

Woody GE

http://www.w3.org/2001/XMLSchema#string

P2860

Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up.

Intravenous drug use and AIDS prevention.

Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.

HIV seroconversion in intravenous drug users in San Francisco, 1985-1990.

Methodological problems in AIDS behavioral research: influences on measurement error and participation bias in studies of sexual behavior.

Methadone treatment and acquired immunodeficiency syndrome.

Prevalence of HIV infection among intravenous drug users in the United States.

Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium.

Patient retention in mobile and fixed-site methadone maintenance treatment.

Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.

P304

97-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P478

113 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

1998-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9722815

http://www.w3.org/2001/XMLSchema#string

P921

P932

1307732

http://www.w3.org/2001/XMLSchema#string